Enzymotec‏ Planning To Raise Over $70M On Wall Street

September 17, 2013 | Israeli nutrition supplement company Enzymotec is poised to raise $70-80 million by holding an IPO on Wall Street. The company, which developed a proprietary method for processing fatty acids, will hold the IPO at a company value of roughly $350 million after money.